Devices › Lithotriptor, biliary mechanical
Device brand name · Lqc
Trapezoid Rx Lithotripter Compatible Basket: medical device reports filed with FDA
212 reports name it, 2007–2009. Manufacturer given most often on reports: Boston Scientific. Product code LQC.
- 212
- device reports naming the brand
- 0% of all MAUDE reports · about 11 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 69.3%
- classified as malfunction
- 75.9% across the product code
- 0.5%
- classified as death, as reported
- 1 reports · not verified by FDA
FDA's MAUDE database holds 212 reports that name the brand "Trapezoid Rx Lithotripter Compatible Basket" (lqc), received between August 2007 and December 2009; the manufacturer given most often on reports is Boston Scientific. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (69.3%), injury (30.2%) and death (0.5%); across all lithotriptor, biliary mechanical reports (product code LQC) death is recorded in 0.4% and malfunction in 75.9%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are other (for use when an appropriate device code cannot be identified) (19.8%), detachment of device component (19.3%) and tip breakage (9.9%). The patient problems coded most often are surgical procedure, additional, nonresorbable materials, unretrieved in body and therapy/non-surgical treatment, additional. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Trapezoid Rx Lithotripter Compatible Basket was received in the five years to August 2026; the latest was received in December 2009.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 2,901 reports carrying product code LQC. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Other (for use when an appropriate device code cannot be identified) | 42 | 19.8% | 1.9% |
| Detachment of device component | 41 | 19.3% | 4.8% |
| Tip breakage | 21 | 9.9% | 1.3% |
| Device, or device fragments remain in patient | 18 | 8.5% | 1% |
| Breakthe device broke | 16 | 7.5% | 43.2% |
| Component(s), broken | 14 | 6.6% | 1.4% |
| Wire(s), breakage of | 14 | 6.6% | 1.2% |
| Device issuea problem with the device | 11 | 5.2% | 1.3% |
| Defective devicethe device was defective | 9 | 4.2% | 0.7% |
| Difficult to removethe device was hard to remove | 9 | 4.2% | 6.3% |
| Handpiece break | 9 | 4.2% | 0.4% |
| Leak/splashthe device leaked | 8 | 3.8% | 0.7% |
| Device damaged prior to usethe device was damaged before use | 7 | 3.3% | 0.3% |
| Tears, rips, holes in device, device material | 7 | 3.3% | 0.3% |
| Device inoperablethe device could not be used | 4 | 1.9% | 0.2% |
| Replace | 4 | 1.9% | 1.7% |
| Mechanical problema mechanical problem | 3 | 1.4% | 0.9% |
| Retraction problem | 3 | 1.4% | 0.4% |
| Difficult or delayed positioning | 2 | 0.9% | 0.1% |
| Difficult to insertthe device was hard to insert | 2 | 0.9% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Surgical procedure, additional | 28 | 13.2% |
| Nonresorbable materials, unretrieved in body | 24 | 11.3% |
| Therapy/non-surgical treatment, additional | 21 | 9.9% |
| No patient involvement | 15 | 7.1% |
| Foreign body, removal of | 9 | 4.2% |
| Therapy/non-surgical treatment, aborted/stopped | 8 | 3.8% |
| Other (for use when an appropriate patient code cannot be identified) | 5 | 2.4% |
| Hospitalization required | 4 | 1.9% |
| Surgical procedure aborted/stopped | 4 | 1.9% |
| Abdominal painstomach or belly pain | 2 | 0.9% |
| Deaththe patient died; cause not stated by this term | 1 | 0.5% |
| Drainage | 1 | 0.5% |
| Fever | 1 | 0.5% |
| Painpain, site not specified | 1 | 0.5% |
| Perforation | 1 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Trapezoid Rx Lithotripter Compatible Basket | Product code LQC | All MAUDE reports |
|---|---|---|---|
| Reports | 212 | 2,901 | 26,136,888 |
| Share of that pool | — | 7.3% | 0% |
| Classified as death, per 1,000 reports | 5 | 4 | 9 |
| Classified as injury | 30.2% | 22.9% | 36.2% |
| Classified as malfunction | 69.3% | 75.9% | 62.3% |
| Filed by the manufacturer | 99.1% | 97.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LQC
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Trapezoid RX | 1,504 | 132 | 0.3% |
| Single Use Mechanical Lithotriptor V | 564 | 57 | 0.5% |
| Trapezoid Rx Lithotripter Compatible Basket Models 1086 1087 1088 | 181 | 0 | 0% |
| Karl Storz | 633 | 0 | 2.1% |
| Flexiva | 229 | 0 | 0% |
| Single Use 3-Lumen Sphincterotome V | 1,767 | 256 | 0.2% |
| Zero Tip | 485 | 44 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Trapezoid Rx Lithotripter Compatible Basket reports
How many FDA reports name Trapezoid Rx Lithotripter Compatible Basket?
212 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (69.3%), injury (30.2%) and death (0.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
other (for use when an appropriate device code cannot be identified) (19.8%), detachment of device component (19.3%), tip breakage (9.9%), device, or device fragments remain in patient (8.5%) and break (7.5%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.1%) and voluntary reports (0.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Trapezoid Rx Lithotripter Compatible Basket was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.